The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3alpha-Hydroxy-5beta-cholan-24-oyl)-L-beta-homo-valine ID: ALA4087107
PubChem CID: 137644831
Max Phase: Preclinical
Molecular Formula: C30H51NO4
Molecular Weight: 489.74
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)[C@@H](CC(=O)O)NC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
Standard InChI: InChI=1S/C30H51NO4/c1-18(2)26(17-28(34)35)31-27(33)11-6-19(3)23-9-10-24-22-8-7-20-16-21(32)12-14-29(20,4)25(22)13-15-30(23,24)5/h18-26,32H,6-17H2,1-5H3,(H,31,33)(H,34,35)/t19-,20-,21-,22+,23-,24+,25+,26-,29+,30-/m1/s1
Standard InChI Key: KNZGLODYRUKNDQ-VVHDBBMBSA-N
Molfile:
RDKit 2D
40 43 0 0 0 0 0 0 0 0999 V2000
30.0710 -4.4946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0710 -5.3117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7763 -5.7162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7763 -4.0818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4815 -4.4946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4826 -5.3117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1869 -5.7172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8947 -5.3099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1848 -4.0828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8956 -4.4934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8943 -2.8546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1811 -3.2642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6051 -3.2652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6020 -4.0868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3824 -4.3437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8679 -3.6808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3874 -3.0143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3639 -5.7214 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.4742 -3.6774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4784 -6.1248 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
32.1800 -4.8990 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
32.8899 -3.6732 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
33.5956 -4.9031 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
33.5998 -2.4474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6429 -2.2381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4428 -2.0712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0984 -1.6288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9874 -2.6805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7873 -2.5136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0428 -1.7374 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.1722 -2.7983 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
37.3319 -3.1230 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.1318 -2.9561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3873 -2.1798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1872 -2.0129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4427 -1.2367 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.7318 -2.6222 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.6764 -3.5654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4209 -4.3416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4763 -3.3985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 1 0
2 3 1 0
3 6 1 0
5 4 1 0
5 6 1 0
5 9 1 0
6 7 1 0
7 8 1 0
8 10 1 0
9 10 1 0
9 12 1 0
10 14 1 0
13 11 1 0
11 12 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 13 1 0
2 18 1 6
5 19 1 1
6 20 1 1
9 21 1 6
10 22 1 1
14 23 1 6
13 24 1 1
17 25 1 0
25 26 1 0
25 27 1 6
26 28 1 0
28 29 1 0
29 30 2 0
17 31 1 6
29 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 36 2 0
35 37 1 0
33 38 1 6
38 39 1 0
38 40 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 489.74Molecular Weight (Monoisotopic): 489.3818AlogP: 6.04#Rotatable Bonds: 8Polar Surface Area: 86.63Molecular Species: ACIDHBA: 3HBD: 3#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 4.57CX Basic pKa: ┄CX LogP: 5.46CX LogD: 2.70Aromatic Rings: ┄Heavy Atoms: 35QED Weighted: 0.39Np Likeness Score: 1.73
References 1. Incerti M, Russo S, Callegari D, Pala D, Giorgio C, Zanotti I, Barocelli E, Vicini P, Vacondio F, Rivara S, Castelli R, Tognolini M, Lodola A.. (2017) Metadynamics for Perspective Drug Design: Computationally Driven Synthesis of New Protein-Protein Interaction Inhibitors Targeting the EphA2 Receptor., 60 (2): [PMID:28005388 ] [10.1021/acs.jmedchem.6b01642 ]